Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

NCT00270127 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Cancer
Neoplasm

Interventions

DRUG: Epoetin alfa

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.